Cover Image

Effect of Pentoxifylline on Apoptosis of Kidney’s Cells Following Acute Methamphetamine Administration in Male Wistar Rats

Shabnam Movassaghi, Ali Yousefi Oudarji, Zahra Nadia Sharifi

Objective(s):  Methylenedioxymethamphetamine (MDMA) is a hallucinogenic drug of abuse which is the most popular drugs in the world and has been shown to induce apoptosis in kidney cells. As Pentoxifylline (PTX) increases cAMP and reduces tumor necrosis factor-α, the present study aimed to investigate the effects of pentoxifylline on kidney damage induced by acute administration of MDMA in male rat.

Materials & methods: Thirty male rats (250-300 g) were randomly divided into five groups: including control (without any intervention), MDMA group ,the group received 7.5 mg/kg MDMA three times at every two hours for one day ,first experimental group, received 100 mg/kg PTX a week before MDMA administration, second experimental group received 100 mg/kg PTX Just in the time of the third injection of MDMA and the third experimental group received 100 mg/kg PTX followed by one dose of MDMA. Two weeks later, kidneys were removed and prepared for H&E staining, TUNEL and western blot techniques. 

Results: histopathological studies showed significantly decrease in the kidney cellular damage, in experimental group 1 compared to MDMA group. The number of TUNEL-positive cells was increased significantly in MDMA group. A significant difference was revealed in the mean number of TUNEL-positive cells between the rats treated with PTX before MDMA administration and MDMA group. Expression of active caspase-3 was significantly increased in the MDMA group. While the PTX treatment could significantly decrease when administrated before MDMA injections.

Conclusion: Pentoxifylline can significantly reduce the severity of lesions in the kidney following administration of MDMA.

Methylenedioxymethamphetamine; Protection; kidney; Pentoxifylline

- Yamamoto BK, Moszczynska A. Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci. 2010;1187:101-21.

- Movassaghi S, Nadia Sharifi Z, Mohammadzadeh F, Soleimani M. Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy).Iran J Basic Med Sci. 2013; 16(8):922-7.

- Karami M, Saeidnia S, Nosrati A. Study of the Hepatoprotective Activity of Methanolic Extract of Feijoa sellowiana Fruits Against MDMA using the Isolated Rat Liver Perfusion System.Iran J Pharm Res. 2013 12(1):85-91.

- Asl SS, Pourheydar B, Dabaghian F, Nezhadi A, Roointan A, Mehdizadeh M. Ecstasy-induced caspase expression alters following ginger treatment. Basic Clin Neurosci. 2013; 4(4):329-33.

- Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ. 2009; 16(1):3–11.

- Malhi H, Guicciardi ME, Gores GJ. Hepatocyte death: a clear and present danger. Physiol Rev. 2010; 90(3):1165–94.

- Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008; 9(1):47–59.

-Tjon JA, Riemann LE .Treatment of intermittent claudication with pentoxifylline and cilostazol. Am J Health Syst Pharm. 2001 15; 58(6):485-93.

-Kang JY, Shin HS. Effects of 1, 7-substituted methylxanthine derivatives on LPS-stimulated expression of cytokines and chemokines in Raw 264.7 and HK-2 cells.J Microbiol Biotechnol. 2015; 25(2):296-301.

-Wang X, Baumann MH, Xu H, Morales M, Rothman RB. 3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther. 2005; 314(3):1002-12.

- Campbell GA, Rosner MH. The agony of ecstasy: MDMA (3, 4 methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol 2008;3:1852-60.

- Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, Segura J, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999; 290:136-45.

- Miranda M, Bosch-Morell F, Johnsen-Soriano S, Barcia J, Almansa I, Asensio S, et al. Oxidative stress in rat retina and hippocampus after chronic MDMA (‘ecstasy’) administration. Neurochem Res 2007;32:1156-62.

-Carvalho M, Hawksworth G, Milhazes N, Borges F, Monks TJ, Fernandes E, et al. Role ofmetabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells. Arch Toxicol 2002;76:581-88.

- Montiel-Duarte C, Ansorena E, Lopez-Zabalza MJ, Cenarruzabeitia E, Iraburu MJ,Cenarruzabeitia E, et al. Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4methylenedioxy methamphetamine ("Ecstasy") on hepatic stellate cells. Biochem Pharmacol 2004; 67:1025–1033.

- Milhazes N, Cunha-Oliveira T, Martins P, Garrido J, Oliveira C, Rego AC, et al. Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. Chem Res Toxicol 2006; 19:1294–1304.

- Fisher AA, Labenski MT, Malladi S, Gokhale V, Bowen ME, Milleron RS, et al. Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. Biochemistry 2007; 46:11090– 11100.

- Moon KH, Abdelmegeed MA, Song BJ. Inactivation of cytosolic aldehyde dehydrogenase via S-nitro sylation in ethanol-exposed rat liver. FEBS Lett 2007; 581:3967–72.

- Stumm G, Schlegel J, Schäfer T, Würz C, Mennel HD, Krieg JC, et al. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J. 1999; 13(9):1065-72.

- Cadet JL, Thiriet N, Jayanthi S.Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne (Paris). 2001;152 Suppl 3:IS57-9.

- Chandra J, Samali A, Orrenius S.Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med. 2000;29(3-4):323-33.

- Mollitt DL, Poulos ND. The role of pentoxifylline in endotoxin-induced alterations of red blood cell deformability and whole blood viscosity in the neonate. J Pediatr Surg. 1991;26:572–574.

- Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R. Insights into the regulation of TNF-α production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics. 2008;63:321–28.

- Ozen S, Saatci U, Tinaztepe K, Bakkaloglu A, Barut A. Urinary tumor necrosis factor levels in primary glomerulopathies. Nephron. 1994; 66:291–4.

- Rodriguez-Morán M, González-González G, Bermúdez-Barba MV, Medina de la Garza CE, Tamez-Pérez HE, Martínez-Martínez FJ, et al. Effects of pentoxifylline on the urinary protein excretion profile of type 2 diabetic patients with microproteinuria: A double-blind, placebo-controlled randomized trial. Clin Nephrol. 2006; 66:3–10.

- Hashemi M.The Study of Pentoxifylline Drug Effects on Renal Apoptosis and BCL-2 Gene Expression Changes Following Ischemic Reperfusion Injury in Rat. Iran J Pharm Res. 2014; 13(1):181-9.

- Stojiljkovic N, Veljkovic S, Mihailovic D, Stoiljkovic M, Radenkovic M, Rankovic G, et al. Protective effects of pentoxifylline treatment on gentamicin-induced nephrotoxicity in rats. Ren Fail2009; 31:54-61.

- Stojiljkovic N, Veljkovic S, Mihailovic D, Stoiljković M, Ranković G, Jovanović I, et al. Pentoxifylline ameliorates glomerular basement membrane ultrastructural changes caused by gentamicin administration in rats. Bosn J Basic Med Sci 2009; 9:239.

- Usta Y, Ismailoglu UB, Bakkaloglu A, Orhan D, Besbas N, Sahin-Erdemli I, et al. Effects of pentoxifylline in adriamycin-induced renal disease in rats. Pediatr Nephrol 2004;19:840-43.

- Ozkurkcugil C, Yilmaz MY, Ozkan L, Kokturk S, Isken T. Protective effects of pentoxifylline on cigarette smoking-induced renal tissue damage in rats. Toxicol Ind Health 2011; 27:335-40.

Refbacks

  • There are currently no refbacks.